7 Biggest Price Target Changes For Monday
February 06, 2017 at 09:57 AM EST
Wedbush lowered the price target for Stemline Therapeutics Inc (NASDAQ: STML) from $19 to $11. Stemline Therapeutics shares ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.